<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Development</journal-id>
<journal-id journal-id-type="iso-abbrev">Development</journal-id>
<journal-id journal-id-type="publisher-id">DEV</journal-id>
<journal-id journal-id-type="hwp">develop</journal-id>
<journal-title-group>
<journal-title>Development (Cambridge, England)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0950-1991</issn>
<issn pub-type="epub">1477-9129</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31371375</article-id>
<article-id pub-id-type="pmc">6737905</article-id>
<article-id pub-id-type="doi">10.1242/dev.172668</article-id>
<article-id pub-id-type="publisher-id">DEV172668</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>203</subject>
<subject>205</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Stem Cells and Regeneration</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Laminin α2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-8539-7462</contrib-id>
<name>
<surname>Ahmed</surname>
<given-names>Maqsood</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marziali</surname>
<given-names>Leandro N.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arenas</surname>
<given-names>Ernest</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feltri</surname>
<given-names>M. Laura</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>ffrench-Constant</surname>
<given-names>Charles</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>MRC Centre of Regenerative Medicine, University of Edinburgh</institution>, <addr-line>Edinburgh EH16 4UU</addr-line>, <country>UK</country></aff>
<aff id="af2"><label>2</label><addr-line>Departments of Biochemistry and Neurology</addr-line>, <institution>School of Medicine and Biomedical Sciences, University at Buffalo</institution>, <addr-line>Buffalo, NY 14203</addr-line>, <country>USA</country></aff>
<aff id="af3"><label>3</label><addr-line>Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics</addr-line>, <institution>Karolinska Institutet</institution>, <addr-line>Stockholm 17177</addr-line>, <country>Sweden</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Author for correspondence (<email>max.ahmed@ed.ac.uk</email>)</corresp>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>2</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>146</volume>
<issue>16</issue>
<elocation-id>dev172668</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="subscription">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://www.biologists.com/user-licence-1-1/</ali:license_ref>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="develop-146-172668.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Development of the central nervous system requires coordination of the proliferation and differentiation of neural stem cells. Here, we show that laminin alpha 2 (lm-α2) is a component of the midbrain dopaminergic neuron (mDA) progenitor niche in the ventral midbrain (VM) and identify a concentration-dependent role for laminin α2β1γ1 (lm211) in regulating mDA progenitor proliferation and survival via a distinct set of receptors. At high concentrations, lm211-rich environments maintain mDA progenitors in a proliferative state via integrins α6β1 and α7β1, whereas low concentrations of lm211 support mDA lineage survival via dystroglycan receptors. We confirmed our findings <italic>in vivo</italic>, demonstrating that the VM was smaller in the absence of lm-α2, with increased apoptosis; furthermore, the progenitor pool was depleted through premature differentiation, resulting in fewer mDA neurons. Examination of mDA neuron subtype composition showed a reduction in later-born mDA neurons of the ventral tegmental area, which control a range of cognitive behaviours. Our results identify a novel role for laminin in neural development and provide a possible mechanism for autism-like behaviours and the brainstem hypoplasia seen in some individuals with mutations of <italic>LAMA2</italic>.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> The proliferation and survival of midbrain dopaminergic neurons is regulated by laminin α2, mutations in which can cause abnormalities in dopaminergic neuron number.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Extracellular matrix</kwd>
<kwd>Neural stem cells</kwd>
<kwd>Laminin</kwd>
<kwd>Integrin</kwd>
<kwd>Dystroglycan</kwd>
<kwd>Dopaminergic neurons</kwd>
<kwd>Congenital muscular dystrophy</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Wellcome Trust</institution>
<institution-id>http://dx.doi.org/10.13039/100010269</institution-id>
</institution-wrap>
</funding-source>
<award-id>602278</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Vetenskapsrådet</institution>
<institution-id>http://dx.doi.org/10.13039/501100004359</institution-id>
</institution-wrap>
</funding-source>
<award-id>VR 2016-01526</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Stiftelsen för strategisk forskning</institution>
<institution-id>http://dx.doi.org/10.13039/100007633</institution-id>
</institution-wrap>
</funding-source>
<award-id>SB16-0065</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>European Commission</institution>
<institution-id>http://dx.doi.org/10.13039/501100000780</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Hjärnfonden</institution>
<institution-id>http://dx.doi.org/10.13039/501100003792</institution-id>
</institution-wrap>
</funding-source>
<award-id>FO2017:0059</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Cancerfonden</institution>
<institution-id>http://dx.doi.org/10.13039/501100002794</institution-id>
</institution-wrap>
</funding-source>
<award-id>CAN 2016/572</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Karolinska Institutet</institution>
<institution-id>http://dx.doi.org/10.13039/501100004047</institution-id>
</institution-wrap>
</funding-source>
<award-id>SG-2018</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
<institution-id>http://dx.doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>5R01EB016629-04</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>